It has been reported that SP-A levels in BAL or serum from patients suffering from idiopathic pulmonary fibrosis correlate with the progression of the disease and can be used to predict survival [34, 38]. This evidence concerns the gene SFTPA2 and idiopathic pulmonary fibrosis.